Health Care

Chart: Measles outbreak this year has been worst of the century

As of June 13, the U.S. has recorded 1,044 cases in 28 states this year, the Centers for Disease Control and Prevention said Monday — the highest number since 1992, when 2,196 cases were reported for the year.

Pfizer buys Array BioPharma for $11.4 billion

A scientist works in a cancer research lab.
An Array BioPharma research lab. Photo: Paul Aiken/Digital First Media/Boulder Daily Camera via Getty Images

Pfizer has agreed to buy Array BioPharma for $48 per share, or $11.4 billion after including Array's debt. Array had never traded above $30 per share before this acquisition.

The bottom line: This is another deep-pocketed move into cancer medicines from a Big Pharma company. Array already is selling 2 FDA-approved drugs for melanoma, and Pfizer is banking on Array's other in-progress therapies to treat patients with colon cancer.